X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank20
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-85.61M
↓ 45% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-58.94M
Historical baseline
PeriodValueYoY Change
TTM$-85.61M-210.4%
2024$-27.58M+70.9%
2023$-94.89M-6.2%
2022$-89.33M-5.7%
2021$-84.54M-45.6%
2020$-58.06M-12.3%
2019$-51.70M-12.7%
2018$-45.88M-45.2%
2017$-31.60M-56.8%
2016$-20.16M-